Delivery Order SPE2DB22D3501-SPE2DB24FWD98
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,544.68 and is a firm fixed-price delivery order with an ultimate completion date of October 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order valued at $1,161.08 for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, placed by the Defense Logistics Agency (DLA). The contract has a period of performance through November 7, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract, valued at $2,322.16, is a delivery order with a firm fixed price. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as the primary vehicle to deliver a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3ml. The $12,174.04 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a major procurer of medical supplies for the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation's Corporate Office Division a $7,256.75 firm-fixed-price delivery order contract for the pharmaceutical product OZEMPIC 1MG/0.75ML. This order was placed under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to DLA facilities...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $3,107.36 Firm Fixed Price delivery order contract has a completion date of July 16, 2024 and was awarded on July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract is a delivery order with a firm fixed price of $1,161.08 and a completion date of June 27, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,741.62, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $2,625.11 and is a Firm Fixed Price Delivery Order. The award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The contract has a ceiling value of $20,898.72 and a completion date of July 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...